# Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

> **NCT07379957** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 450 (estimated)

## Conditions studied

- Kidney Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07379957
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2029-02
- **Final completion:** 2029-02
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379957, "Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT07379957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*